- Corporate Officers - H
- Hawran Paul W
Insider Trading History of Hawran Paul W
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Hawran Paul W since 2006.
The trader's CIK number is 1123344.
At the time of the last reporting, Hawran Paul W was the Chief Financial Offi of Plus Therapeutics, Inc.. (stock ticker symbol PSTV).
Also see all insider trading activities at Plus Therapeutics, Inc..
Note that in the past
HAWRAN PAUL W also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Sequenom Inc (SQNM) by Hawran Paul W
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2009 | SQNM | 7,000 | $94,162 | 0 | $0 | 0 | $0 |
| 2008 | SQNM | 10,000 | $71,330 | 0 | $0 | 0 | $0 |
| 2007 | SQNM | 70,000 | $323,460 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Neurocrine Biosciences Inc (NBIX) by Hawran Paul W
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2006 | NBIX | 0 | $0 | 115,481 | $2,306,963 | 0 | $0 |
Yearly summary of insider trading at Plus Therapeutics, Inc. (CYTX) by Hawran Paul W
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2011 | CYTX | 5,000 | $16,020 | 0 | $0 | 0 | $0 |
| 2010 | CYTX | 10,000 | $47,400 | 0 | $0 | 0 | $0 |
| 2009 | CYTX | 45,000 | $188,000 | 0 | $0 | 0 | $0 |
Insider trading activities at 3 companies by Hawran Paul W:
1. Sequenom Inc (SQNM)
2. Neurocrine Biosciences Inc (NBIX)
3. Plus Therapeutics, Inc. (CYTX)
Table 1. Insider trading of Sequenom Inc (SQNM) by Hawran Paul W
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2009-03-13 | SQNM | Buy | 2,000 | 13.46 | 26,912 |
| 2009-03-04 | SQNM | Buy | 5,000 | 13.45 | 67,250 |
| 2008-02-26 | SQNM | Buy | 10,000 | 7.13 | 71,330 |
| 2007-11-05 | SQNM | Buy | 10,000 | 8.83 | 88,320 |
| 2007-06-01 | SQNM | Buy | 20,000 | 4.64 | 92,820 |
| 2007-05-22 | SQNM | Buy | 10,000 | 3.97 | 39,670 |
| 2007-05-17 | SQNM | Buy | 10,000 | 3.56 | 35,650 |
| 2007-05-10 | SQNM | Buy | 10,000 | 3.19 | 31,850 |
| 2007-05-11 | SQNM | Buy | 10,000 | 3.52 | 35,150 |
Table 2. Insider trading of Neurocrine Biosciences Inc (NBIX) by Hawran Paul W
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2006-05-17 | NBIX | Sale | 115,481 | 19.98 | 2,306,963 |
Table 3. Insider trading of Plus Therapeutics, Inc. (CYTX) by Hawran Paul W
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2011-09-14 | CYTX | Buy | 5,000 | 3.20 | 16,020 |
| 2010-05-24 | CYTX | Buy | 5,000 | 4.65 | 23,235 |
| 2010-05-19 | CYTX | Buy | 5,000 | 4.83 | 24,165 |
| 2009-11-25 | CYTX | Buy | 5,000 | 4.90 | 24,500 |
| 2009-11-24 | CYTX | Buy | 5,000 | 4.74 | 23,700 |
| 2009-11-18 | CYTX | Buy | 20,000 | 4.25 | 84,900 |
| 2009-11-17 | CYTX | Buy | 5,000 | 3.98 | 19,900 |
| 2009-11-12 | CYTX | Buy | 10,000 | 3.50 | 35,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Hawran Paul W
(Chief Financial Offi of Plus Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.